• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS SECONDARY SET; SET, SECONDARY, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS SECONDARY SET; SET, SECONDARY, INTRAVASCULAR Back to Search Results
Model Number 11448964
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Information (3190)
Event Date 07/31/2018
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: 0.9% normal saline and a bag of levofloxacin, therapy date (b)(6) 2018.No product will be returned as the anonymous customer could not be contacted.The root cause of this failure was not identified.
 
Event Description
Received a copy of the fda sus voluntary event report which states, "nurse reported that a new secondary tubing was primed with 0.9% normal saline and a bag of levofloxacin was spiked and initiated into the secondary tubing.The primary tubing was infusing with the normal saline.The nurse discovered sediment (precipitation), in the secondary drip chamber and the secondary line when levofloxacin was initiated.No precipitation was seen in the levofloxacin bag.The rn took down drug bag and tubing.A new bag of medication (same lot expiration) and secondary tubing (same lot and expiration) were used and the precipitation did not occur.Concomitant medical levofloxacin 750mg /150 ml mg milligram(s), mfr: claris life sciences, dc # (b)(4), lot # aob0183, exp: 01/31/2020, intravenous drip." there was no report of patient harm.The report lists product problem, but "other serious (important medical events)" is checked for adverse events.Since the reporter was anonymous no further information could be obtained regarding the "other serious" classification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS SECONDARY SET
Type of Device
SET, SECONDARY, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer (Section G)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
ade ajibade
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key7860054
MDR Text Key119691197
Report Number9616066-2018-01558
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10885403234743
UDI-Public10885403234743
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K790582
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 08/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/10/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model Number11448964
Device Catalogue Number11448964
Device Lot Number18027055
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/28/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PRI TUBING, THERAPY DATE (B)(6) 2018
Patient Outcome(s) Other;
-
-